Search - tctmd.com

Displaying 621 - 640 of 666

Sort: Relevancy | Date

News Daily News

Hospital-Acquired Thrombocytopenia Increases Risk of Hospital Bleeding, 1-Year Mortality

May 05, 2014

News Daily News

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

L.A. McKeown

April 11, 2014

News Daily News

Meta-analysis: Bone Marrow Mononuclear Cell Therapy Fails to Show Efficacy in Acute MI

Yael L. Maxwell

April 08, 2014

News Conference News ACC 2014

Intramyocardial Injection of Stem Cells Shows Promise for Severe Ischemic Heart Failure

Yael L. Maxwell

March 31, 2014

News Daily News

Readmissions Higher with PCI vs CABG for Left Main Disease

March 14, 2014

News Daily News

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

Yael L. Maxwell

February 26, 2014

News Daily News

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Caitlin E. Cox

February 26, 2014

News Daily News

Bleeding Common but Often Unreported in ACS Patients on Antiplatelet Therapy

L.A. McKeown

February 06, 2014

News Daily News

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Yael L. Maxwell

January 01, 2014

News Daily News

Early QOL Advantage of CABG Over PCI for Diabetic Patients Disappears After 2 Years

L.A. McKeown

October 15, 2013

News Daily News

CADUCEUS: Autologous Stem Cells Safely Reverse Some MI Damage

September 27, 2013

News Daily News

Analysis Strengthens Support for Enoxaparin Over Heparin in PCI for STEMI

L.A. McKeown

September 20, 2013

News Daily News

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

Yael L. Maxwell

August 19, 2013

News Daily News

Apixaban Lowers Hospitalization Rate vs. Aspirin in A-fib Patients

Jason Kahn

August 05, 2013

News Daily News

Apixaban Reduce el Índice de Hospitalizaciones compardo con la Aspirina en Pacientes con Fibrilación Auricular

Jason Kahn

August 05, 2013

Presentation

The Effects of Apixaban on Hospitalizations in Patients With Different Types of Atrial Fibrillation

Presenter: Stefan H. Hohnloser

August 01, 2013

News Daily News

REOPEN-AMI Published: Adenosine Reduces ‘No-Reflow’ in STEMI Patients

July 05, 2013

News Daily News

Long-term Mortality Higher After Incomplete Revascularization

June 20, 2013

News Daily News

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Yael L. Maxwell

June 07, 2013

News Daily News

Meta-analysis Confirms Connection Between High-Dose NSAIDs, Vascular Risk

Caitlin E. Cox

June 03, 2013

Advertisement

Hospital-Acquired Thrombocytopenia Increases Risk of Hospital Bleeding, 1-Year Mortality

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

Meta-analysis: Bone Marrow Mononuclear Cell Therapy Fails to Show Efficacy in Acute MI

Intramyocardial Injection of Stem Cells Shows Promise for Severe Ischemic Heart Failure

Readmissions Higher with PCI vs CABG for Left Main Disease

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Bleeding Common but Often Unreported in ACS Patients on Antiplatelet Therapy

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Early QOL Advantage of CABG Over PCI for Diabetic Patients Disappears After 2 Years

CADUCEUS: Autologous Stem Cells Safely Reverse Some MI Damage

Analysis Strengthens Support for Enoxaparin Over Heparin in PCI for STEMI

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

Apixaban Lowers Hospitalization Rate vs. Aspirin in A-fib Patients

Apixaban Reduce el Índice de Hospitalizaciones compardo con la Aspirina en Pacientes con Fibrilación Auricular

The Effects of Apixaban on Hospitalizations in Patients With Different Types of Atrial Fibrillation

REOPEN-AMI Published: Adenosine Reduces ‘No-Reflow’ in STEMI Patients

Long-term Mortality Higher After Incomplete Revascularization

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Meta-analysis Confirms Connection Between High-Dose NSAIDs, Vascular Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content